Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Dividends payables Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

SRx Health Solutions (SRXH) Convertible Debt (2018 - 2025)

SRx Health Solutions' Convertible Debt history spans 3 years, with the latest figure at $4.5 million for Q3 2025.

For Q3 2025, Convertible Debt changed N/A year-over-year to $4.5 million; the TTM value through Sep 2025 reached $4.5 million, changed N/A, while the annual FY2025 figure was $4.5 million, N/A changed from the prior year.
Convertible Debt reached $4.5 million in Q3 2025 per SRXH's latest filing, up from $1.0 million in the prior quarter.
In the past five years, Convertible Debt ranged from a high of $4.5 million in Q3 2025 to a low of $100000.0 in Q4 2023.